Insulin resistance has been proposed as one of the causes of poor glycemic control in youth with type 1 diabetes who have excess weight or obesity.
Read More »Production Assistant, Diabetes In Control
Sleep as Medicine
Do you prescribe sleep for your patients? Follow the link to see how you and your colleagues compare.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #112: Diabetes and Sleep Apnea Part 2
OSA epidemiology and risk factors: The prevalence of OSA varies considerably between studies, mainly due to differences in the population studied, study designs, and the method and criteria used to diagnose OSA. A prevalence of 4% in men and 2% in women has traditionally been quoted in many populations. The prevalence from three well-conducted studies with similar design from Wisconsin, Pennsylvania, and Spain showed an OSA prevalence of 17–26% in men and 9–28% in women and a prevalence of 9–14% and 2–7% for men and women with moderate to severe OSA. These studies used a two-stage sampling design which allows some degree of estimate of the “self-selection” bias which is usually a significant problem in OSA studies.
Read More »Point-Counterpoint, Part 1: How to Overcome the Complexities of Treatment Decisions for Your Patients with Type 2 Diabetes
In the last four issues, we discussed a new software that can go through over 6 million possible treatments using anywhere from 1 to 5 drugs for an effective treatment for type 2 diabetes. Along with determining the best treatment for the patient, it includes the ability to put in what the patient can afford in their budget. Dr. John Interlandi, one of our readers, has submitted a counterpoint to using this software to decide the best treatment options. In Part 1, Dr. Interlandi shares his concerns about the use of AI in medical decision making.
Read More »Meta-Analysis Evaluates Long-Term Safety of SGLT2’s
Short-term efficacy and safety of SGLT2 inhibitors have been well established, but what happens with long-lasting use of these medications?
Read More »Breastfeeding Reduces Risk of Developing Diabetes
30-year study shows effects of breastfeeding on diabetes incidence in women of child-bearing age.
Read More »A Comparison of Safety and Efficacy of Semaglutide vs. Exenatide ER
GLP-1 agonists randomized showdown. Which agent is better?
Read More »How Efficient Are Voice-Operated Apps for Insulin Pumps?
Evaluating if bolus calculators for insulin pumps can be accurately calibrated by speech recognition.
Read More »Timing is Everything: A Focus on Gluten Initiation into Infants’ Diets
A study examining the timing of foods and its associated risk to islet autoimmunity.
Read More »Treatment Cost
How does cost play in your determination for treatment? Follow the link to see how you and your colleagues compare.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.